ITGAM and neoplasm: As shown in Figure 3A, the frequency of tumor-infiltrating CD11b+Gr-1+ myeloid cells in the orthotopic Hepa mice was significantly lower in icaritin-treated mice compared to that in the control (35.5 ± 3.2% vs. 58.8 ± 7.5%).